Understanding how DNA changes affect insulin-producing cells in diabetes
The DNA methylome-based regulation of functional beta-cell mass
This study is looking at how changes in DNA can help turn certain cells in the pancreas into insulin-producing beta cells, which could lead to better treatments for type 2 diabetes, helping patients manage their condition more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10849878 on NIH RePORTER |
What this research studies
This research investigates the role of DNA methylation in the development of insulin-producing beta cells from pancreatic progenitor cells during embryonic development. By examining how these DNA modifications influence the growth and function of beta cells, the study aims to uncover mechanisms that could lead to improved treatments for type 2 diabetes. The approach involves analyzing genetic markers and their effects on cell differentiation and function, which may provide insights into how to enhance beta cell mass and function in patients. Patients may benefit from findings that could lead to new therapeutic strategies for diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with type 2 diabetes, particularly those with a family history of the condition.
Not a fit: Patients with type 1 diabetes or those whose diabetes is not related to beta cell function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that enhance the function and mass of insulin-producing cells, potentially improving diabetes management.
How similar studies have performed: Previous research has shown promising results in understanding the role of DNA methylation in cell differentiation, suggesting that this approach may yield valuable insights.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Gu, Guoqiang — Vanderbilt University
- Study coordinator: Gu, Guoqiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.